| NAME |
BUPRENORPHINE HCL 8MG/NALOXONE HCL 2MG TAB,SUBLINGUAL |
| VA GENERIC NAME |
BUPRENORPHINE/NALOXONE |
| DOSAGE FORM |
TAB,SUBLINGUAL |
| FDA MED GUIDE |
Buprenorphine-Naloxone_SL_Tab_(Generic)_(2022).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Schedule III |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
BUPRENORPHINE/NALOXONE TAB,SUBLINGUAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
BUPRENORPHINE 8MG/NALOXONE 2MG SL TAB |
| VA PRODUCT IDENTIFIER |
B0491 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
TAB |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4016379 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
|
